David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Ezio Di Nucci
Jack Alan Reynolds
Learn more about PhilPapers
Journal of Medicine and Philosophy 31 (5):465 – 482 (2006)
There are individuals, including children, dying needlessly in poverty-stricken third world countries. Many of these deaths could be prevented if pharmaceutical companies provided the drugs needed to save their lives. Some believe that because pharmaceutical companies have the power to save lives, and because they can do so with little effort, they have a special obligation. I argue that there is no distinction, with respect to obligations and responsibilities, between pharmaceutical companies and other types of companies. As a result, to hold pharmaceutical companies especially responsible for saving lives in third world countries is unjustified.
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
Linda Klebe Treviño (2010). Managing Business Ethics: Straight Talk About How to Do It Right. Wiley.
W. D. Ross (2002). The Right and the Good. Clarendon Press.
Immanuel Kant (1996). The Metaphysics of Morals. Cambridge University Press.
Jonathan Dancy (1993). Moral Reasons. Blackwell.
R. Edward Freeman (2001). A Stakeholder Theory of the Modern Corporation. Perspectives in Business Ethics Sie 3:144.
Citations of this work BETA
Matthew Lee & Jillian Kohler (2010). Benchmarking and Transparency: Incentives for the Pharmaceutical Industry's Corporate Social Responsibility. [REVIEW] Journal of Business Ethics 95 (4):641-658.
Elizabeth A. Kitsis (2011). Physicians and the Pharmaceutical Industry: Working Together on Conflict of Interest. American Journal of Bioethics 11 (1):51 - 52.
Janet Malek (2006). Introduction. Journal of Medicine and Philosophy 31 (5):441 – 446.
David Badcott (2013). Big Pharma: A Former Insider's View. [REVIEW] Medicine, Health Care and Philosophy 16 (2):249-264.
James M. Huebner (2014). Moral Psychology and the Intuition That Pharmaceutical Companies Have a ‘Special’ Obligation to Society. Journal of Business Ethics 122 (3):501-510.
Similar books and articles
Azam Golam (2008). Moral Obligation of Pharmaceutical Companies Towards HIV Victims in Developing Countries. The Dhaka University Studies 64 (1):197-212.
Pepe Lee Chang (2006). Who's in the Business of Saving Lives? Journal of Medicine and Philosophy 31 (5):465-482.
Nicole Hassoun (2012). Global Health Impact: A Basis for Labeling and Licensing Campaigns? Developing World Bioethics 12 (3):121-134.
Włodzimierz Kubiak (2005). Medicine and Pharmacy — Facts and Myths About the Development of an Innovative Pharmaceutical Industry in Poland. Science and Engineering Ethics 11 (1):41-51.
R. Stephen Parker & Charles E. Pettijohn (2003). Ethical Considerations in the Use of Direct-to-Consumer Advertising and Pharmaceutical Promotions: The Impact on Pharmaceutical Sales and Physicians. [REVIEW] Journal of Business Ethics 48 (3):279-290.
Eng Tuck Cheah, Wen Li Chan & Corinne Lin Lin Chieng (2007). The Corporate Social Responsibility of Pharmaceutical Product Recalls: An Empirical Examination of U.S. And U.K. Markets. [REVIEW] Journal of Business Ethics 76 (4):427 - 449.
William Flanagan & Gail Whiteman (2005). “AIDS is Not a Business”. International Corporate Responsibility Series 2:375-391.
Denis Gordon Arnold (ed.) (2009). Ethics and the Business of Biomedicine. Cambridge University Press.
Richard T. de George (2005). Intellectual Property and Pharmaceutical Drugs. Business Ethics Quarterly 15 (4):549-575.
Lawrence Masek (2000). The Doctrine of Double Effect, Deadly Drugs, and Business Ethics. Business Ethics Quarterly 10 (2):483-495.
Added to index2009-01-28
Total downloads20 ( #194,933 of 1,911,915 )
Recent downloads (6 months)2 ( #324,434 of 1,911,915 )
How can I increase my downloads?